EU indices mixed | TA focus on Thyssenkrupp


European stocks report | Essentra | Bayer | Thyssenkrupp ...

Stocks (3)

Yesterday, European stocks were broadly lower. The Stoxx Europe 600 Index dropped 0.8%, Germany's DAX 30 lost 0.7%, France's CAC 40 slid 0.6% and the U.K.'s FTSE 100 was down 0.8%.

77% of STOXX 600 constituents traded lower or unchanged yesterday.
63% of the shares trade above their 20D MA vs 73% Wednesday (above the 20D moving average).
54% of the shares trade above their 200D MA vs 55% Wednesday (above the 20D moving average).

The Euro Stoxx 50 Volatility index added 1.56pt to 23.56, a new 52w high.

3mths relative high: Industrial
3mths relative low: Healthcare

Europe Best 3 sectors
travel & leisure, media, personal & household good

Europe worst 3 sectors
basic resources, real estate, health care

The 10yr Bund yield rose 2bps to -0.42% (above its 20D MA). The 2yr-10yr yield spread fell 2bps to -25bps (below its 20D MA).

GE 07:00: Jul Import Prices YoY, exp.: -5.1%
GE 07:00: Jul Import Prices MoM, exp.: 0.6%
GE 07:00: Sep GfK Consumer Confidence, exp.: -30%
FR 07:45: Jul Household Consumption MoM, exp.: 9%
FR 07:45: Q2 GDP Growth Rate QoQ final, exp.: -5.9%
FR 07:45: Aug Inflation Rate MoM Prel, exp.: 0.4%
FR 07:45: Aug Harmonised Inflation Rate MoM Prel, exp.: 0.4%
FR 07:45: Aug Harmonised Inflation Rate YoY Prel, exp.: 0.9%
FR 07:45: Jul PPI MoM, exp.: 0.7%
FR 07:45: Aug Inflation Rate YoY Prel, exp.: 0.8%
EC 10:00: Aug Consumer Confidence final, exp.: -15
EC 10:00: Aug Consumer Inflation expectations, exp.: 17.5
EC 10:00: Aug Economic Sentiment, exp.: 82.3
EC 10:00: Aug Industrial Sentiment, exp.: -16.2
EC 10:00: Aug Services Sentiment, exp.: -26.1
UK 14:05: BoE Gov Bailey speech

In Asian trading hours, EUR/USD bounced to 1.1831 and GBP/USD climbed to 1.3224. USD/JPY rose further to 106.81 before facing a drop as Japanese Prime Minister Shinzo Abe plans to resign due to health reasons, according to NHK.

Spot gold rebounded to $1,934 an ounce.

Essentra, a supplier of plastic and fibre products, posted 1H results: "HY 2020 revenue decreased 11.5% (-11.7% at constant exchange) to £448.4m. On a LFL basis, revenue decreased 8.5%. (...) On an adjusted basis, operating profit was down 40.0% (-40.0% at constant FX) at £29.0m. (...) On an adjusted basis, net income of £17.2m was down 48.0% (48.4% at constant FX) and adjusted basic earnings per share decreased by 48.3% (48.5% at constant FX) to 6.2p."

Bayer's, a pharmaceutical group, 11 billion dollars U.S. settlement deal risks partial collapse, as U.S. District Judge Vince Chhabria said he is concerned the company has "manipulated" the settlement process since announcing its plan in June to resolve 125,000 cases related to its weedkillers, according to Bloomberg. The judge will revisit in a month whether to keep the litigation on hold for settlement talks to continue or to let more trials proceed.

Thyssenkrupp, an industrial engineering group, was downgraded to "underweight" from "equalweight" at Morgan Stanley.
From a weekly point of view, the share is capped by a bearish trend line drawn since September 2018. Furthermore the 50 DMA is playing a resistance role above the stock. Below the overlap area at 9.25E look for the horizontal resistance at 3.9E and 3.28E in extension.

Source: GAIN Capital, TradingView

Fraport, an airport operator, was downgraded to "hold" from "buy" at Deutsche Bank.

Prysmian, a manufacturer of electric power transmission and telecommunications cables, was upgraded to "overweight" from "neutral" at JPMorgan.

Deutsche Post: E1.15, Fresenius Medical Care: E1.2

More from Equities

From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.